Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Kevin Meyer Elias, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Victoria Diniz M, Sun SY, Barsottini C, Viggiano M, Signorini Filho RC, Sanches Ozane Pimenta B, Elias KM, Horowitz NS, Braga A, Berkowitz RS. Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study. J Med Internet Res. 2018 Sep 24; 20(9):e10897. PMID: 30249575.
    View in: PubMed
  2. Elias KM, Tsantoulis P, Tille JC, Vitonis A, Doyle LA, Hornick JL, Kaya G, Barnes L, Cramer DW, Puppa G, Stuckelberger S, Hooda J, Dietrich PY, Goggins M, Kerr CL, Birrer M, Hirsch MS, Drapkin R, Labidi-Galy SI. Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors. J Pathol. 2018 Sep 19. PMID: 30229909.
    View in: PubMed
  3. Elias KM, Stone AB, McGinigle K, Tankou JI, Scott MJ, Fawcett WJ, Demartines N, Lobo DN, Ljungqvist O, Urman RD. The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS® and ERAS® USA Societies. World J Surg. 2018 Aug 16. PMID: 30116862.
    View in: PubMed
  4. Padrón L, Rezende-Filho J, Amim-Junior J, Sun SY, Cortés-Charry R, Maestá I, Elias KM, Horowitz NS, Braga A, Berkowitz RS. In Reply. Obstet Gynecol. 2018 Jul; 132(1):218. PMID: 29939922.
    View in: PubMed
  5. Gockley AA, Elias KM. Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction. Cancer Treat Rev. 2018 Sep; 69:66-71. PMID: 29909222.
    View in: PubMed
  6. Nitecki R, Berkowitz RS, Elias KM, Goldstein DP, Horowitz NS. Gestational Trophoblastic Disease Electronic Consults: What Do Patients and Physicians Want to Know? Int J Gynecol Cancer. 2018 May; 28(4):824-828. PMID: 29324544.
    View in: PubMed
  7. Cramer DW, Elias KM. Perspectives on Ovarian Cancer From SEER: Today and Tomorrow. J Natl Cancer Inst. 2018 Apr 28. PMID: 29718448.
    View in: PubMed
  8. Padrón L, Rezende Filho J, Amim Junior J, Sun SY, Charry RC, Maestá I, Elias KM, Horowitz N, Braga A, Berkowitz RS. Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy. Obstet Gynecol. 2018 Apr; 131(4):652-659. PMID: 29528932.
    View in: PubMed
  9. Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, Seckl MJ. Does a human chorionic gonadotropin level of over 20,000?IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? Eur J Obstet Gynecol Reprod Biol. 2018 Apr; 223:50-55. PMID: 29477553.
    View in: PubMed
  10. Dreaden EC, Kong YW, Quadir MA, Correa S, Suárez-López L, Barberio AE, Hwang MK, Shi AC, Oberlton B, Gallagher PN, Shopsowitz KE, Elias KM, Yaffe MB, Hammond PT. RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors. Bioeng Transl Med. 2018 Jan; 3(1):26-36. PMID: 29376131.
    View in: PubMed
  11. Braga A, Campos V, Filho JR, Lin LH, Sun SY, de Souza CB, da Silva RCAF, Leal EAS, Silveira E, Maestá I, Madi JM, Uberti EH, Viggiano M, Elias KM, Horowitz N, Berkowitz RS. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma? Gynecol Oncol. 2018 02; 148(2):239-246. PMID: 29248195.
    View in: PubMed
  12. Worley MJ, Elias KM, Horowitz NS, Quade BJ, Berkowitz RS. Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute. Gynecol Oncol. 2018 01; 148(1):5-11. PMID: 29217138.
    View in: PubMed
  13. Elias KM, Fendler W, Stawiski K, Fiascone SJ, Vitonis AF, Berkowitz RS, Frendl G, Konstantinopoulos P, Crum CP, Kedzierska M, Cramer DW, Chowdhury D. Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife. 2017 10 31; 6. PMID: 29087294.
    View in: PubMed
  14. Maestá I, Nitecki R, Horowitz NS, Goldstein DP, de Freitas Segalla Moreira M, Elias KM, Berkowitz RS. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience. Gynecol Oncol. 2018 01; 148(1):161-167. PMID: 29092742.
    View in: PubMed
  15. Dantas PRS, Maestá I, Filho JR, Junior JA, Elias KM, Howoritz N, Braga A, Berkowitz RS. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors? Gynecol Oncol. 2017 11; 147(2):364-370. PMID: 28927899.
    View in: PubMed
  16. Elias KM. Understanding Enhanced Recovery After Surgery Guidelines: An Introductory Approach. J Laparoendosc Adv Surg Tech A. 2017 Sep; 27(9):871-875. PMID: 28704133.
    View in: PubMed
  17. Nitzschke S, Offodile AC, Cauley RP, Frankel JE, Beam A, Elias KM, Gibbons FK, Salim A, Christopher KB. Long term mortality in critically ill burn survivors. Burns. 2017 Sep; 43(6):1155-1162. PMID: 28606748.
    View in: PubMed
  18. Chung TKH, Cheung TH, Yim SF, Yu MY, Chiu RWK, Lo KWK, Lee IPC, Wong RRY, Lau KKM, Wang VW, Worley MJ, Elias KM, Fiascone SJ, Smith DI, Berkowitz RS, Wong YF. Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women. Gynecol Oncol. 2017 08; 146(2):334-339. PMID: 28587748.
    View in: PubMed
  19. Liu CY, Elias KM, Howitt BE, Lee LJ, Feltmate CM. Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: A before and after study. Gynecol Oncol. 2017 05; 145(2):248-255. PMID: 28363672.
    View in: PubMed
  20. Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet. 2017 May; 34(5):627-631. PMID: 28299550.
    View in: PubMed
  21. Elias KM, Harvey RA, Hasselblatt KT, Seckl MJ, Berkowitz RS. Type I interferons modulate methotrexate resistance in gestational trophoblastic neoplasia. Am J Reprod Immunol. 2017 06; 77(6). PMID: 28295835.
    View in: PubMed
  22. Lin LH, Maestá I, Braga A, Sun SY, Fushida K, Francisco RPV, Elias KM, Horowitz N, Goldstein DP, Berkowitz RS. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review. Gynecol Oncol. 2017 Apr; 145(1):88-95. PMID: 28132722.
    View in: PubMed
  23. Braga A, Torres B, Burlá M, Maestá I, Sun SY, Lin L, Madi JM, Uberti E, Viggiano M, Elias KM, Berkowitz RS. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation? Gynecol Oncol. 2016 Dec; 143(3):558-564. PMID: 27640962.
    View in: PubMed
  24. Elias KM, Emori MM, Westerling T, Long H, Budina-Kolomets A, Li F, MacDuffie E, Davis MR, Holman A, Lawney B, Freedman ML, Quackenbush J, Brown M, Drapkin R. Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. JCI Insight. 2016 Aug 18; 1(13). PMID: 27617304.
    View in: PubMed
  25. Cramer DW, Elias KM. A prognostically relevant miRNA signature for epithelial ovarian cancer. Lancet Oncol. 2016 08; 17(8):1032-1033. PMID: 27402146.
    View in: PubMed
  26. Peetz AB, Brat GA, Rydingsward J, Askari R, Olufajo OA, Elias KM, Mogensen KM, Lesage JL, Horkan CM, Salim A, Christopher KB. Functional status, age, and long-term survival after trauma. Surgery. 2016 09; 160(3):762-70. PMID: 27375087.
    View in: PubMed
  27. Esselen KM, Terry KL, Samuel A, Elias KM, Davis M, Welch WR, Muto MG, Ng SW, Berkowitz RS. Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery? Gynecol Oncol. 2016 08; 142(2):255-60. PMID: 27261327.
    View in: PubMed
  28. Braga A, Moraes V, Maestá I, Amim Júnior J, Rezende-Filho Jd, Elias K, Berkowitz R. Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women. Int J Gynecol Cancer. 2016 06; 26(5):984-90. PMID: 26905335.
    View in: PubMed
  29. Braga A, Burlá M, Freitas F, Uberti E, Viggiano M, Sun SY, Maestá I, Elias KM, Berkowitz RS. Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries. J Reprod Med. 2016 May-Jun; 61(5-6):224-9. PMID: 27424363.
    View in: PubMed
  30. Berkowitz RS, Horowitz NS, Elias K, Goldstein DP. Gestational Trophoblastic Disease: Presentations from the XVIIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2016 May-Jun; 61(5-6):185-6. PMID: 27424355.
    View in: PubMed
  31. Braga A, Maestá I, Rocha Soares R, Elias KM, Custódio Domingues MA, Barbisan LF, Berkowitz RS. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2016 09; 215(3):336.e1-336.e12. PMID: 27094961.
    View in: PubMed
  32. Choi YE, Meghani K, Brault ME, Leclerc L, He YJ, Day TA, Elias KM, Drapkin R, Weinstock DM, Dao F, Shih KK, Matulonis U, Levine DA, Konstantinopoulos PA, Chowdhury D. Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer. Cell Rep. 2016 Jan 26; 14(3):429-439. PMID: 26774475; PMCID: PMC4731274.
  33. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1611. PMID: 25821001.
    View in: PubMed
  34. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1606-7. PMID: 25631066.
    View in: PubMed
  35. Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation. Gynecol Oncol. 2015 Nov; 139(2):283-7. PMID: 26383828.
    View in: PubMed
  36. Elias KM, Christopher KB. The authors reply. Crit Care Med. 2015 Sep; 43(9):e399-400. PMID: 26274733.
    View in: PubMed
  37. Elias KM, Emori MM, Papp E, MacDuffie E, Konecny GE, Velculescu VE, Drapkin R. Beyond genomics: critical evaluation of cell line utility for ovarian cancer research. Gynecol Oncol. 2015 Oct; 139(1):97-103. PMID: 26321251; PMCID: PMC4587360 [Available on 10/01/16].
  38. Quraishi SA, Litonjua AA, Elias KM, Gibbons FK, Giovannucci E, Camargo CA, Christopher KB. Association between pre-hospital vitamin D status and hospital-acquired new-onset delirium. Br J Nutr. 2015 Jun 14; 113(11):1753-60. PMID: 26067807; PMCID: PMC4634007.
  39. Mirkovic J, Elias K, Drapkin R, Barletta JA, Quade B, Hirsch MS. GATA3 expression in gestational trophoblastic tissues and tumours. Histopathology. 2015 Nov; 67(5):636-44. PMID: 25753145.
    View in: PubMed
  40. Elias KM, Moromizato T, Gibbons FK, Christopher KB. Derivation and validation of the acute organ failure score to predict outcome in critically ill patients: a cohort study. Crit Care Med. 2015 Apr; 43(4):856-64. PMID: 25746746.
    View in: PubMed
  41. Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF. Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. Int J Cancer. 2015 Aug 15; 137(4):776-83. PMID: 25626421.
    View in: PubMed
  42. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015 Apr; 22(4):1341-8. PMID: 25287437.
    View in: PubMed
  43. Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J Clin Invest. 2014 Jun; 124(6):2611-25. PMID: 24762435; PMCID: PMC4038562.
  44. Labidi-Galy SI, Clauss A, Ng V, Duraisamy S, Elias KM, Piao HY, Bilal E, Davidowitz RA, Lu Y, Badalian-Very G, Györffy B, Kang UB, Ficarro S, Ganesan S, Mills GB, Marto JA, Drapkin R. Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors. Oncogene. 2015 Jan 15; 34(3):373-83. PMID: 24469047.
    View in: PubMed
  45. Elias KM, Labidi-Galy SI, Vitonis AF, Hornick JL, Doyle LA, Hirsch MS, Cramer DW, Drapkin R. Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms. Gynecol Oncol. 2014 Feb; 132(2):328-33. PMID: 24342438; PMCID: PMC3929430.
  46. Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012 May-Jun; 57(5-6):254-8. PMID: 22696822.
    View in: PubMed
  47. Elias KM, Liu J, Hirsch MS, Drapkin R. Expression of dachshund homolog 2 in ovarian serous adenocarcinoma. J Clin Oncol. 2011 May 20; 29(15_suppl):e15544. PMID: 28023945.
    View in: PubMed
  48. Singh M, Kindelberger D, Nagymanyoki Z, Ng SW, Quick CM, Elias KM, Yamamoto H, Fichorova R, Fulop V, Berkowitz RS. Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 2011 Jul; 122(1):178-82. PMID: 21514631.
    View in: PubMed
  49. Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010 May-Jun; 55(5-6):208-12. PMID: 20626176.
    View in: PubMed
  50. Huh WK, Sill MW, Darcy KM, Elias KM, Hoffman JS, Boggess JF, Alvarez RD, Long HJ, O'Malley DM, Birrer MJ. Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus. Gynecol Oncol. 2010 May; 117(2):248-54. PMID: 20189232.
    View in: PubMed
  51. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008 Apr 10; 452(7188):773-6. PMID: 18337720.
    View in: PubMed
  52. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, O'Shea JJ. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 2008 Feb 01; 111(3):1013-20. PMID: 17951529; PMCID: PMC2214761.
  53. Wei L, Laurence A, Elias KM, O'Shea JJ. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem. 2007 Nov 30; 282(48):34605-10. PMID: 17884812.
    View in: PubMed
  54. Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ. Biomarker discovery in epithelial ovarian cancer by genomic approaches. Adv Cancer Res. 2007; 96:1-22. PMID: 17161674.
    View in: PubMed
  55. Ryan CK, Elias K, Sahasrabudhe DM, Eberly S, Khorana AA. The host response and colon cancer prognosis. J Clin Oncol. 2004 Jul 15; 22(14_suppl):9565. PMID: 28016678.
    View in: PubMed
  56. Elias K. Letter: Osteoblastic repair of osteolytic tumor metastases following treatment. JAMA. 1975 Jan 13; 231(2):135. PMID: 162786.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Elias's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (253)
Explore
_
Co-Authors (59)
Explore
_
Similar People (58)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_